DOCUMENT
99 -- Monoclonal Antibody Generation - RFP for Monoclonal Antibody Generation
- Notice Date
- 6/27/2008
- Notice Type
- RFP for Monoclonal Antibody Generation
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bldg 427, Room 12, Frederick, Maryland, 21702
- ZIP Code
- 21702
- Solicitation Number
- S08-244
- Archive Date
- 8/9/2008
- Point of Contact
- Matt Desantis,, Phone: 301/228-4002
- E-Mail Address
-
desantisma@mail.nih.gov
- Small Business Set-Aside
- N/A
- Description
- The Clinical Proteomic Technologies for Cancer (CPTC) initiative was established with the goal of creating technologies, data, reagents and reference materials, analysis systems and infrastructure as a basis for advancing discovery research and clinical applications. More information about the initiative can be found at http://proteomics.cancer.gov. As part of the CPTC, a series of renewable and highly characterized affinity binding reagents will be generated and made available to the research community. Detailed standard operating procedures (SOP's) will be made available along with characterization data through a web portal. This will ensure that experiments can be both repeated and compared among researchers. The specific objective of this scope of work is to generate antibodies from antigens already generated under the CPTC. There are forty-two antigens (see list below) that will be used in the generation and screening for new monoclonal antibodies. Once a set of antibodies are generated and screened by the contractor for each antigen, the antibodies will be sent to SAIC-F and undergo further screening and characterization including but not limited to Western Blot, enzyme immunoassay (EIA), surface plasmon resonance (SPR), immuno capture and mass spectrometry, and immuno histochemistry (IHC). The data from all phases of the characterization, i.e. from contractor and other entities selected by NCI will be made public through the associated web portal. The final antibodies and associated hybridoma cells will be made available to the scientific community through a distributor or repository selected by the NCI. All questions must be submitted via email by 5:00 PM, Friday, July 11, 2008. Please send to Matt DeSantis at desantisma@mail.nih.gov.
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=fdf6bcd19249592f67b4a190e840cc3e&tab=core&_cview=1)
- Document(s)
- RFP for Monoclonal Antibody Generation
- File Name: Solicitation S08-244 Monoclonal Antibody Generation (RFP - Monoclonal Antibodies 6-27-08.doc)
- Link: https://www.fbo.gov//utils/view?id=2322933c571fa5021c3dace10100aacb
- Bytes: 320.00 Kb
- Note: If links are broken, refer to Point of Contact above or contact the FBO Help Desk at 877-472-3779.
- File Name: Solicitation S08-244 Monoclonal Antibody Generation (RFP - Monoclonal Antibodies 6-27-08.doc)
- Place of Performance
- Address: Contractor, United States
- Record
- SN01603143-W 20080629/080627221017-fdf6bcd19249592f67b4a190e840cc3e (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |